A Combinatorial Biomarker for Infection Diagnosis in Children
NCT ID: NCT05971901
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
770 participants
OBSERVATIONAL
2023-02-24
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary objectives:
* Qualitative evaluation of indication as well as adherence to the test result.
* Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
NCT01911143
Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala
NCT05314816
SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients
NCT04615000
Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children
NCT06852846
TARGet Kids! COVID-19 Study of Children and Families
NCT04449978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BV use cases
cases in whom BV was ordered
BV
The use of the BV test, ordered at the discretion of the treating physician
BV non-use cases
cases in whom BV was not ordered
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BV
The use of the BV test, ordered at the discretion of the treating physician
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Requirement of at least one BV test during medical presentation
Exclusion Criteria
5 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität des Saarlandes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cihan Papan
Principial Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cihan Papan, MD
Role: PRINCIPAL_INVESTIGATOR
Universität des Saarlandes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sana Kliniken
Berlin, , Germany
Universitätsklinikum Bonn
Bonn, , Germany
Saarland University
Homburg, , Germany
Universitätsklinikum Würzburg
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
233/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.